FREMONT, Calif., July 27, 2021 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Cytek Biosciences or Cytek) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the closing of its initial public offering of an aggregate of 14,564,635 shares…

Click here to view the original article.